Autor(es):
Pereira, Sofia 
Data: 2010
Origem: Acta Médica Portuguesa
Detalhes do Documento
Cardiovascular risk management in the hypertensive patient.
Descrição
Hypertension is a major cardiovascular risk factor. The treatment of the individual with hypertension is aimed to reduce cardiovascular mortality and morbidity. With such aim the management of hypertension goes beyond arterial pressure lowering and involves the treatment of thrombotic risk with antiplatelet therapy, treatment of hyperlipidemia with lifestyle measures and statins, and diabetes prevention with lifestyle measures. For the hypertensive patient with concomitant cardiovascular disease or diabetes, pharmacological treatment is consensual. However, in primary prevention the institution of drug therapy must be judicious to guarantee that benefit surpass costs. Hypertension is a major cardiovascular risk factor. The treatment of the individual with hypertension is aimed to reduce cardiovascular mortality and morbidity. With such aim the management of hypertension goes beyond arterial pressure lowering and involves the treatment of thrombotic risk with antiplatelet therapy, treatment of hyperlipidemia with lifestyle measures and statins, and diabetes prevention with lifestyle measures. For the hypertensive patient with concomitant cardiovascular disease or diabetes, pharmacological treatment is consensual. However, in primary prevention the institution of drug therapy must be judicious to guarantee that benefit surpass costs.
Hypertension is a major cardiovascular risk factor. The treatment of the individual with hypertension is aimed to reduce cardiovascular mortality and morbidity. With such aim the management of hypertension goes beyond arterial pressure lowering and involves the treatment of thrombotic risk with antiplatelet therapy, treatment of hyperlipidemia with lifestyle measures and statins, and diabetes prevention with lifestyle measures. For the hypertensive patient with concomitant cardiovascular disease or diabetes, pharmacological treatment is consensual. However, in primary prevention the institution of drug therapy must be judicious to guarantee that benefit surpass costs. Hypertension is a major cardiovascular risk factor. The treatment of the individual with hypertension is aimed to reduce cardiovascular mortality and morbidity. With such aim the management of hypertension goes beyond arterial pressure lowering and involves the treatment of thrombotic risk with antiplatelet therapy, treatment of hyperlipidemia with lifestyle measures and statins, and diabetes prevention with lifestyle measures. For the hypertensive patient with concomitant cardiovascular disease or diabetes, pharmacological treatment is consensual. However, in primary prevention the institution of drug therapy must be judicious to guarantee that benefit surpass costs.
Tipo de Documento
Artigo
Idioma Português
Idioma Português
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||